Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Rexulti price, strengths & recalls

Brand of brexpiprazole (generic)

Pharmacies pay $1,484.71 for 30 tablets of Rexulti 0.25 mg tablet this week, and from $1,484.48 to $1,486.84 across its 6 priced strengths and forms. Its official label last changed on May 28, 2026.

Medicare price 2028Brand
Pharmacies pay$1,484.71for 30 tablets of 0.25 mg tabletNo change in 4 weeks
Fair cash price
$1,717.92
Strengths
6
Makers
1
Updated
Nov 11

Rexulti price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.25 mg tablet Brand$49.49$1,484.71 / 30 tabletsNo change+2.7%
0.5 mg tablet Brand$49.48$1,484.48 / 30 tabletsNo change+2.3%
1 mg tablet Brand$49.56$1,486.84 / 30 tabletsNo change+2.6%
2 mg tablet Brand$49.52$1,485.74 / 30 tabletsNo change+2.6%
3 mg tablet Brand$49.49$1,484.72 / 30 tabletsNo change+2.4%
4 mg tablet Brand$49.55$1,486.42 / 30 tablets+0.2%+2.6%

The lowest cost per tablet is 0.5 mg tablet at $49.48. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Rexulti vs generic brexpiprazole

There is no generic version of Rexulti on the market yet. Its last listed patent or exclusivity runs to April 12, 2033 - generics often follow, though court cases and settlements can move the date either way.

GenericBrexpiprazole prices

Medicare negotiated price

Rexulti was selected for Medicare price negotiation. Its negotiated price takes effect on January 1, 2028; the price itself is published by the end of November 2026.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Every Medicare negotiated price

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for rexulti? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMay 28, 2026
Version26 of 23
EffectiveMay 6, 2026
Read the label

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

This drug has a boxed warning

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer's disease. (5.1)

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. Safety and effectiveness of REXULTI have not been established in pediatric patients with MDD. (5.2, 8.4)

Increased Mortality in Elderly Patients with Dementia-Related Psychosis

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer's disease [see Warnings and Precautions (5.1)].

Suicidal Thoughts and Behaviors

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric patients and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.2)]. The safety and effectiveness of REXULTI have not been established in pediatric patients with MDD [see Warnings and Precautions (5.2), Use in Specific Populations (8.4)].

Recent major changes (as listed on the label)

Warnings and Precautions (5.6) | 4/2026 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA205422 · Otsuka
First approved
July 10, 2015 (11 years ago)
Latest approved change
April 30, 2026
Approved label
PDF, May 5, 2026
Generic makers
None on the market
Last patent listed
April 12, 2033
Exclusivity ends
May 9, 2028

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Rexulti questions

How much does rexulti cost without insurance?

Pharmacies pay about $1,484.71 for 30 tablets of rexulti 0.25 mg tablet ($49.49 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,717.92. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Rexulti?

Yes: brexpiprazole. Compare brexpiprazole prices.

Is rexulti in shortage?

No shortage is reported for rexulti right now. We check the national shortage list every day.

Has rexulti been recalled?

No recalls are on record for rexulti.

When did the rexulti label last change?

The official label was last updated on May 28, 2026 (version 26). See what changed.

Does Medicare have a negotiated price for Rexulti?

Yes - Rexulti was selected and its negotiated price starts January 1, 2028.

Talk about rexulti

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.